PharmiWeb.com - Global Pharma News & Resources
15-Jul-2019

Coronary Artery Bypass Graft Procedures Market Size to Cross USD 20 Billion by 2026

The Global Coronary Artery Bypass Graft Procedures Market Size projected to register USD 20 billion by 2026, registering at a CAGR growth of 2.0% over the forecast period 2019 to 2026.

The demand for coronary artery bypass (CABG) procedure has been encouraged, such as increased incidence of multiple cardiovascular illnesses such as Coronary Heart Disease (CHD), myocardial infarction, and stroke combined with increasing demand for minimally invasive operations. In addition, owing to better patency rates and long-term outcomes, technical advances and increasing preference are expected to propel the CABG market for the internal thoracic artery grease.

In addition, increasing costs of health care boost the economic cost to patients without insurance cover as the cost of CABGs is lower for individuals to travel to developing nations. In turn, this increases demand in developing countries for medical tourism. Some of the important variables driving demand for CABG processes in developing countries are the availability of advantages such as enhanced health care, low operating price and better hospitality.

With sales of USD 11 billion, North America has resulted the coronary artery bypass grafting system market in 2018, with a forecast increase of 2,1 percent at the fastest CAGR. Some of the main factors given for North America's elevated market share include the easy access of graft, elevated healthcare expenditures per capita, the number of target people in the US and Canada, sedentary lifestyles, and increased cardiovascular deaths.

In 2016, approximately 363,452 fatalities in U.S. coronary heart disease are estimated in the estimated estimates released by the American Heart Association. Additionally, CABG and related processes are expected to benefit favorably from favourable reimbursement policies and promising federal projects in order to support the therapy of cardiovascular diseases.

Download Free Sample Report Pages at https://www.acumenresearchandconsulting.com/request-sample/1500

Today, the worldwide market for the bypass grafts is motivated by an increase in cardiovascular disease incidence and the increasing need for geriatric population and for the repetition of revascularisations.

Cardiovascular and aging populations are on the rise, helping to boost worldwide market demand for bypass grafts. The development of the coronary blood pressure bypass graft industry is also anticipated to result from an increasing use of endoscopic vessel harvesting equipment and anastomosis support systems. However, the increased health budget, bad reimbursement and payment models as well as market leadership consolidation act as a significant impediment to this market's development.

The worldwide coronary artery bypass market is anticipated to develop at a healthy CAGR over its predicted era (2015-2026 with fast technological progress in the health sector, reducing cardiovascular diseases, increasing geriatric populations, and the growing use of endoscopic vessel harvesting equipment and anastomosis aid equipment.

Long operative incisions through the internal thigh and/or calf are traditionally required. Investigations that compare traditional approaches with endoscopic techniques reveal that patients are usually less complicated, less leg pain and less hospitalized with the endoscopic harvest techniques.

Coronary artery bypass graft is an alternative for chosen patient groups with important heart blockages. The CABG bypass graft may be a joint vein or the internal artery of the chest.

Key Players amp; Strategies

KARL STORZ GmbH amp; Co Medtronic, TERUMO Co., are the key players in the worldwide coronary artery bypass graft industry. Other includes KG, Boston Scientific, Ethicon, Neograft, MAQUET Holding, Sorin Group, Boston Scientific. Edwards Lifesciences, and Genesee Biomedical Inc.

These actors implement organic and organic growth strategies for expanding their product portfolio, strengthening geographic scope, increasing their client base and capturing market shares.

View Detail Information at https://www.acumenresearchandconsulting.com/coronary-artery-bypass-graft-procedures-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Coronary Artery Bypass Graft Procedures
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Coronary Artery Bypass Graft Procedures Market By Graft Type
1.2.2.1. Global Coronary Artery Bypass Graft Procedures Market Revenue and Growth Rate Comparison By Graft Type (2015-2026)
1.2.2.2. Global Coronary Artery Bypass Graft Procedures Market Revenue Share By Graft Type in 2017
1.2.2.3. Internal Thoracic Artery Grafts
1.2.2.4. Saphenous Vein Grafts
1.2.2.5. Other Grafts
1.2.3. Coronary Artery Bypass Graft Procedures Market By Surgery Type
1.2.3.1. Global Coronary Artery Bypass Graft Procedures Market Revenue and Growth Rate Comparison By Surgery Type (2015-2026)
1.2.3.2. Global Coronary Artery Bypass Graft Procedures Market Revenue Share By Surgery Type in 2017
1.2.3.3. Quadruple CABG Surgery
1.2.3.4. Triple CABG Surgery
1.2.3.5. Double CABG Surgery
1.2.3.6. Single CABG Surgery
1.2.4. Coronary Artery Bypass Graft Procedures Market by Geography
1.2.4.1. Global Coronary Artery Bypass Graft Procedures Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Coronary Artery Bypass Graft Procedures Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Coronary Artery Bypass Graft Procedures Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Coronary Artery Bypass Graft Procedures Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Coronary Artery Bypass Graft Procedures Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Coronary Artery Bypass Graft Procedures Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Coronary Artery Bypass Graft Procedures Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Coronary Artery Bypass Graft Procedures Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Coronary Artery Bypass Graft Procedures Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Coronary Artery Bypass Graft Procedures Major Manufacturers in 2017

CHAPTER 4. CORONARY ARTERY BYPASS GRAFT PROCEDURES MARKET BY GRAFT TYPE

4.1. Global Coronary Artery Bypass Graft Procedures Revenue By Graft Type
4.2. Internal Thoracic Artery Grafts
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Saphenous Vein Grafts
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Other Grafts
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. CORONARY ARTERY BYPASS GRAFT PROCEDURES MARKET BY SURGERY TYPE

5.1. Global Coronary Artery Bypass Graft Procedures Revenue By Surgery Type
5.2. Quadruple CABG Surgery
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Triple CABG Surgery
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Double CABG Surgery
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Single CABG Surgery
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT PROCEDURES MARKET BY COUNTRY

6.1. North America Coronary Artery Bypass Graft Procedures Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Coronary Artery Bypass Graft Procedures Market Revenue Share Comparison, 2015 amp; 2026 (%)
6.3. U.S.
6.3.1. U.S. Coronary Artery Bypass Graft Procedures Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE CORONARY ARTERY BYPASS GRAFT PROCEDURES MARKET BY COUNTRY

7.1. Europe Coronary Artery Bypass Graft Procedures Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Coronary Artery Bypass Graft Procedures Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT PROCEDURES MARKET BY COUNTRY

8.1. Asia-Pacific Coronary Artery Bypass Graft Procedures Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Coronary Artery Bypass Graft Procedures Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT PROCEDURES MARKET BY COUNTRY

9.1. Latin America Coronary Artery Bypass Graft Procedures Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Coronary Artery Bypass Graft Procedures Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT PROCEDURES MARKET BY COUNTRY

10.1. Middle East Coronary Artery Bypass Graft Procedures Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Coronary Artery Bypass Graft Procedures Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA CORONARY ARTERY BYPASS GRAFT PROCEDURES MARKET BY COUNTRY

11.1. Africa Coronary Artery Bypass Graft Procedures Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Coronary Artery Bypass Graft Procedures Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Graft Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Surgery Type, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. KARL STORZ GmbH amp; Co. KG
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Medtronic
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. TERUMO Co.
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Boston Scientific
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Ethicon
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Neograft
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. MAQUET Holding
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Sorin Group
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Boston Scientific
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Edwards Lifesciences
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Genesee Biomedical Inc.
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. Others
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Product Portfolio
12.12.5. Key Developments
12.12.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

Request for Customization at https://www.acumenresearchandconsulting.com/request-customization/1500

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/1500

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 15-Jul-2019